经尿道膀胱肿瘤汽化电切术联合表柔比星治疗非肌层浸润性膀胱癌的临床效果

Abstract
Figure/Table
References (14)
Related Citation (0)

Download: PDF (0 KB) HTML (26 KB)
Export: BibTeX | EndNote (RIS)

Abstract ObjectiveTo explore the clinical effect of transurethral bladder tumor vaporizing electrotomy combined with epi in the treatment of non-muscular infiltrating bladder cancer.Methods40 patients of non-muscle invasive bladder cancer treated in our hospital from March 2014 to March 2016 were divided into observation group (n=20)and control group (n=20).Two groups were given transurethral electrovaporization of bladder tumor treatment,the control group with hydroxycamptothecin or mitoxantrone for bladder perfusion,observation group with epirubicin for bladder perfusion.The catheter indwelling time,operation time,adverse reactions and recurrence were compared between the two groups.ResultsThere was no significant difference in indwelling time and operation time between the two groups(P>0.05).There was no significant difference in the incidence of adverse reactions between the two groups(χ2=0.28,P=0.60).There was no significant difference in recurrence rate between the two groups (χ2=0.20,P=0.66).ConclusionTransurethral electrovaporization resection of bladder tumor combined with epirubicin in the treatment of non-muscle invasive bladder cancer is effective,the recurrence rate is low,worthy of promotion.

Key words： Transurethral resection of bladder tumor Epirubicin Non muscle invasive bladder cancer

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	HUANG Zhi-cheng
	PENG Dong
	CHEN Zhi-lin
	WAN Pei
	ZHU Yu-guang
	CHEN Nan-hui

Cite this article:

HUANG Zhi-cheng,PENG Dong,CHEN Zhi-lin, et al. Clinical effect of transurethral resection of bladder tumor combined with epirubicin in the treatment of non muscle invasive bladder cancer[J]. 中国当代医药, 2018, 25(5): 89-91.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2018/V25/I5/89

[1]	吴晓鸣，何屹，吴建惠，等.磷酸肌醇3激酶/蛋白激酶B信号通路在膀胱癌中的表达及与膀胱癌干细胞的关系[J].中华实验外科杂志，2017，34（7）：1224-1226.
[2]	崔洪雨，杨俊，孔祥斌，等.经尿道同期手术治疗非肌层浸润性膀胱癌及前列腺增生对膀胱癌复发影响的Meta分析[J].现代泌尿外科杂志，2015，20（12）：889-894，897.
[3]	牛吉瑞，王海，范欣荣，等.肌层浸润性膀胱癌患者根治性膀胱切除术的预后分析[J].中国医药，2015，10（9）：1344-1346.
[4]	李美凤，周小庆，曾菁，等.膀胱内灌注丝裂霉素与表柔比星预防膀胱癌术后复发的临床研究[J].中国临床药理学杂志，2014，30（6）：500-502.
[5]	李美凤，周小庆，曾菁，等.羟基喜树碱与表柔比星膀胱内灌注化疗预防膀胱癌术后复发的临床研究[J].中国临床药理学杂志，2015，31（15）：1503-1505.
[6]	余大海，王超奇，王明，等.膀胱癌电切术后膀胱灌注多柔比星脂质体治疗浅表性膀胱癌的疗效观察[J].现代肿瘤医学，2015，23（9）：1253-1255.
[7]	吴文博，程龙，廖正明，等.腹腔镜膀胱癌根治术与开放性膀胱癌根治术临床疗效比较[J].临床外科杂志，2015，23（2）：110-112.
[8]	梁健铭，杨占斌，汪小明，等.表柔比星和丝裂霉素膀胱灌注预防浅表性膀胱癌复发的临床研究[J].广西医科大学学报，2015，32（3）：395-397.
[9]	李振华.膀胱部分切除术与经尿道膀胱肿瘤电切术治疗非肌层浸润性膀胱癌的临床疗效分析[J].中国医学创新，2015，12（10）：31-33.
[10]	孙建涛，杨金辉，魏澎涛，等.二次根治性经尿道膀胱肿瘤电切术加介入栓塞化疗治疗肌层浸润膀胱癌的研究[J].中国现代医学杂志，2015，25（29）：106-108.
[11]	薛斌，何秉勋，康厚彬，等.经尿道膀胱肿瘤电切术联合吡柔比星膀胱灌注治疗对浅表性膀胱癌患者预后及血清相关因子的影响[J].实用癌症杂志，2016，31（6）：1027-1029.
[12]	陈励碧，金超，黄晓华，等.经尿道膀胱肿瘤电切术对膀胱癌患者生存情况及不良反应的影响[J].癌症进展，2016，14（12）：1261-1263.
[13]	张洪宜，商亭.经尿道膀胱肿瘤电切术联合表柔比星膀胱灌注治疗膀胱癌临床分析[J].吉林医学，2014，35（36）：8098-8099.
[14]	毕晓军，李健，范连慧，等.表柔比星对膀胱癌细胞中miR-21 表达的影响[J].安徽医药，2016，20（7）：1268-1270.